Variant report
Variant | esv3332051 |
---|---|
Chromosome Location | chr2:56823350-56840215 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543571701 | chr2:56833418-56833419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556902459 | chr2:56833426-56833427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145277320 | chr2:56833447-56833448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114454542 | chr2:56833452-56833453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149168850 | chr2:56833456-56833457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146467750 | chr2:56833459-56833460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541923624 | chr2:56833531-56833532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561855511 | chr2:56833544-56833545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530535050 | chr2:56833545-56833546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550320957 | chr2:56833547-56833548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570164869 | chr2:56833578-56833579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11688435 | chr2:56833580-56833581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183690404 | chr2:56833581-56833582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370584731 | chr2:56833583-56833584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555948033 | chr2:56835604-56835605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556021606 | chr2:56835605-56835606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575588458 | chr2:56835627-56835628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs148161563 | chr2:56835630-56835631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544899684 | chr2:56835636-56835637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75066467 | chr2:56835646-56835647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533391698 | chr2:56835743-56835744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540714685 | chr2:56835749-56835750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540293830 | chr2:56836213-56836214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10200031 | chr2:56836222-56836223 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs57457595 | chr2:56836237-56836238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs551248486 | chr2:56836238-56836239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564804886 | chr2:56836298-56836299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527604780 | chr2:56836316-56836317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546943639 | chr2:56836332-56836333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115899113 | chr2:56836337-56836338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535957465 | chr2:56836357-56836358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549895586 | chr2:56836406-56836407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569336665 | chr2:56836412-56836413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181435414 | chr2:56836415-56836416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185859560 | chr2:56836422-56836423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538075948 | chr2:56836430-56836431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578237854 | chr2:56836442-56836443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534503100 | chr2:56836447-56836448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs3948576 | chr2:56836468-56836469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs562027821 | chr2:56836483-56836484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567806813 | chr2:56836485-56836486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs36006605 | chr2:56836492-56836493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10187925 | chr2:56836494-56836495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs542736541 | chr2:56836495-56836496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190614092 | chr2:56836518-56836519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576478301 | chr2:56836532-56836533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2112027 | chr2:56836621-56836622 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs564741550 | chr2:56836623-56836624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113851729 | chr2:56836624-56836625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183188505 | chr2:56836635-56836636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56833400-56833600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr2:56835600-56835800 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr2:56836200-56837400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
4 | chr2:56837200-56837600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr2:56837400-56838200 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr2:56837600-56838000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr2:56837600-56838400 | Enhancers | HSMM | muscle |
8 | chr2:56838200-56840800 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr2:56838400-56840600 | Weak transcription | HSMM | muscle |